Form 4: Aura Biosciences' Chief Legal Officer Conor Kilroy Reports Stock Sale to Cover Tax Obligations
SEC Form 4 Filing
Conor Kilroy, Chief Legal Officer and Secretary of Aura Biosciences, sold 7,162 shares of common stock on April 16, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On April 16, 2025, Conor Kilroy, the Chief Legal Officer and Secretary of Aura Biosciences, sold 7,162 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $5.49, with individual transactions ranging from $5.48 to $5.49.
- Following the transaction, Kilroy directly owns 179,313 shares of Aura Biosciences.
- Kilroy has granted power of attorney to Amy Elazzouzi and Elisabet de los Pinos to handle SEC filings related to company stock.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing related to stock transactions by a company officer, indicating a neutral sentiment.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives.
Key Dates
| Date | Description |
|---|---|
| 04/16/2025 | Date of stock sale transaction and Power of Attorney execution. |
Keywords
Aura Biosciences, Conor Kilroy, Form 4, Stock Sale, Tax Obligations, Restricted Stock Units, Power of Attorney, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.